03.13.18
Gemini version available ♊︎Session in Bavaria to Discuss the Abuses of the European Patent Office Later Today
Summary: The EPO shambles in Munich have gotten the attention of more Bavarian politicians, more so in light of the Constitutional complaint against the UPC (now dealt with by the German FCC, which saw merit in the complaint)
LATER today Bavarian politicians will talk about EPO scandals.
This comes only days after EPO management wasted a lot of money flooding/dominating the media — German media included — with spin.
“Why does the EPO still fall for the CRISPR monopolies that even the USPTO rejects?”Having significantly lowered patent quality and granted patents at a pace several times greater than applications come in (creating a massive deficit/shortage of work), such spin is crucial to them because layoffs are on the way and they want to somehow justify these or claim these to be a “necessary evil” (no such thing).
Recall the propaganda patterns found in the latest annual report, which we covered in the following posts: (there have been some more puff pieces about it since, but we’re just ignoring them because they’re not unique in any way)
- EPO Hires External PR Agencies to Control Coverage of Its Annual Report, Deny Investigative Journalism
- EPO Patent ‘Growth’ Not Achieved But Demanded/Mandated by Battistelli, by Lowering Quality of Patents/Services
- The EPO’s PR Department Receives Return on Investment (Puff Pieces) for Paying the Media
- EPO Annual Results/Report: Revenue From Patent Applications is Apparently Down Yet Again and Work is Running Out
“As I said before,” one person told us, “the EPO has an insane and counterproductive pricing model. It should be free to have your patent granted, but to be denied the patent should cost a bundle. The incentives now are completely backwards.”
“It’s a problem for many firms and applicants who obtained EPs over the past few decades (when examination was still strict).”I responded with: “Because of who it’s designed to “serve and protect”: Siemens, Philips etc. (while discouraging SMEs and always pretending to cherish SMEs and “inventors”)…”
“For the first time ever,” I told the EPO after it had posted this (yesterday), the EPO is “said to be laying off staff [...] after Battistelli destroyed the Office and quality of EPs…”
Why does the EPO still fall for the CRISPR monopolies that even the USPTO rejects? We wrote about that yesterday and so did The Scientist. There was also this new announcement yesterday:
Kuros announced today that its Dutch subsidiary, Kuros Biosciences BV, has been granted the European patent, EP3021878, entitled “Method for producing an osteoinductive calcium phosphate and products thus obtained” by the European Patent Office (EPO).
We often wonder how many companies and organisations are aware of the decline in quality — and thus devaluation — of European Patents (EPs). It’s a problem for many firms and applicants who obtained EPs over the past few decades (when examination was still strict). █
ᶃ Gemini Space
This post is also available in 
Content is available under CC-BY-SA